Biomaterials Market Forecasts to 2030 – Global Analysis By Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramics and Natural Biomaterials), By Application (Cardiovascular, Orthopedic, Smart Healthcare, Ophthalmology, Dental, Plastic Surgery and Ot

Biomaterials Market Forecasts to 2030 – Global Analysis By Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramics and Natural Biomaterials), By Application (Cardiovascular, Orthopedic, Smart Healthcare, Ophthalmology, Dental, Plastic Surgery and Other Applications) and By Geography

According to Stratistics MRC, the Global Biomaterials Market is accounted for $180.1 billion in 2023 and is expected to reach $515.3 billion by 2030 growing at a CAGR of 16.2% during the forecast period. Biomaterials are specialized materials designed for use in medical and healthcare applications, where they interact with biological systems to aid in diagnostics, treatment, or tissue repair. These materials are engineered to be biocompatible, meaning they can integrate seamlessly with the body without causing harm or adverse reactions. Biomaterials encompass a wide range of substances, including metals, polymers, ceramics, and composites, and are used in various medical devices, implants, drug delivery systems, and tissue engineering.

According to the March 2022 update of the World Health Organization, caries of permanent teeth affect an estimated 2 billion individuals worldwide, while caries of primary teeth affect 520 million children annually.

Market Dynamics

Driver

Increasing demand for implantable devices

As the aging population grows, so does the need for medical devices like orthopedic implants and cardiovascular stents. Biomaterials play a pivotal role in enhancing the biocompatibility and longevity of these devices. Moreover, advancements in minimally invasive surgical techniques have expanded the range of implantable medical devices, increasing their prevalence. The demand for biomaterials is further driven by the rising incidence of chronic diseases that require surgical interventions. As a result, the biomaterials market continues to expand, driven by the critical role it plays in improving the quality of life for patients requiring implantable medical devices.

Restraint

Stringent clinical & regulatory processes

The development and commercialization of biomaterials for medical applications require extensive clinical testing and adherence to stringent regulatory guidelines, leading to prolonged research-to-market timelines and significant financial investments. These processes, intended to ensure safety and efficacy, can deter smaller companies from entering the market due to high compliance costs. Additionally, regulatory hurdles may result in delays and increased expenses for established biomaterial manufacturers. While essential for patient safety, these strict requirements limit the speed of innovation and market entry, thereby hindering the rapid introduction of novel biomaterials into the healthcare sector.

Opportunity

Growing healthcare market in emerging economies

With improving access to healthcare and rising disposable incomes, these regions are witnessing a surge in demand for advanced medical treatments and devices, including those reliant on biomaterials. As healthcare infrastructure expands the need for biomaterials in orthopedics, cardiovascular treatments, and tissue engineering rises. This offers a substantial market for biomaterial manufacturers to address unmet medical needs, foster research collaborations, and provide cost-effective solutions tailored to the demands of these developing healthcare systems. It positions biomaterial companies to tap into new markets and contribute to enhanced medical care in emerging economies.

Threat

Shortage of skilled surgeons

The successful application of biomaterials often relies on proficient surgical techniques and practices. However, a shortage of well-trained and experienced surgeons can hinder the effective utilization of biomaterials in various medical procedures, from implantations to tissue engineering. This limitation may lead to suboptimal patient outcomes, complications, and inefficiencies, affecting the reputation of biomaterials in healthcare. Addressing this threat requires investments in medical education and training programs to ensure that an adequate number of skilled surgeons are available to work with biomaterials, maximizing their potential and expanding their positive impact in patient care.

Covid-19 Impact

The COVID-19 pandemic has had a notable impact on the biomaterials industry. On one hand, the demand for biomaterials surged in response to the urgent need for medical supplies and equipment, such as ventilators, personal protective equipment (PPE), and diagnostic tools. Biomaterials played a critical role in developing and manufacturing these healthcare essentials. On the other hand, the pandemic disrupted global supply chains, leading to delays in production and distribution of biomaterials. Clinical trials and research projects in the biomaterials sector were also affected. As the world grappled with the pandemic, the industry adapted by prioritizing research on biomaterials for vaccine development and diagnostics, further highlighting the sector's importance in public health.

The metallic biomaterials segment is expected to be the largest during the forecast period

The metallic biomaterials have a significant share in the Biomaterials market. These materials exhibit high strength, durability, and corrosion resistance, making them ideal for applications like orthopedic implants (e.g., joint replacements and dental fixtures) and cardiovascular stents. Metallic biomaterials, often made of materials such as titanium and stainless steel, offer excellent mechanical properties, ensuring longevity and stability within the human body. While they provide robust structural support, considerations for biocompatibility and the reduction of potential allergic reactions are essential in their design and development, allowing metallic biomaterials to contribute significantly to the advancement of medical treatments and procedures.

The orthopaedic segment is expected to have the highest CAGR during the forecast period

The orthopaedic has the highest CAGR within the Biomaterials market over the forecast period. These biomaterials, such as metals, polymers, ceramics, and composites, are carefully engineered to replace or repair damaged or degenerated bones, joints, and ligaments. They are employed in a wide range of orthopedic devices, including artificial joints (such as hip and knee replacements), bone plates, and screws. Biocompatibility, mechanical strength, and wear resistance are key attributes in orthopedic biomaterials to ensure the longevity and effectiveness of implants. Advancements in orthopedic biomaterials have significantly improved the quality of life for patients with orthopedic conditions, making them a vital component of orthopedic medicine.

Region with largest share

North America holds a significant position and expected to hold a largest share over the forecast period. The region's robust presence in the medical and dental fields drives the demand for biomaterials used in various applications, such as orthopedics, cardiovascular, and dental implants. Furthermore, an emphasis on technological advancements, coupled with increasing awareness of the benefits of biomaterials, fuels innovation and market growth. Stringent regulatory guidelines also contribute to product quality and safety. North America continues to be a key player in the global biomaterials market, with a strong focus on medical advancements and improving patient outcomes.

Region with highest CAGR

The Asia-Pacific region witnessed the highest CAGR in the Biomaterials market, driven by its rapidly expanding healthcare sector, increasing investments in research and development, and a growing geriatric population. The region's rising incidence of chronic diseases, coupled with a burgeoning middle-class population, fuels the demand for biomaterials in applications like orthopedics, cardiovascular, and wound healing. Additionally, the adoption of advanced medical technologies and increasing healthcare expenditure drive the use of biomaterials for innovative medical devices and implants. Asia-Pacific as a significant contributor to the global biomaterials market, with substantial growth potential and opportunities for both domestic and international biomaterial companies.

Key players in the market

Some of the key players in Biomaterials Market include Corbion N.V, Royal DSM, Noble Biomaterials Inc., Covalon Technologies Ltd., Zimmer Biomet Holdings, Inc., Stryker Corporation (Wright Medical Group N.V), Victrex Plc, Evonik Industries, Carpenter Technology Corporation, Medtronic plc, Berkeley Advanced Biomaterials and Collagen Matrix.

Key Developments

In June 2023, Covation Biomaterials, a worldwide provider of bio-based solutions, emerged as an independent business after the Huafon Group acquired DuPont Biomaterials.

In December 2022, Orthopedics Inc., and Invibio Biomaterial Solutions made an announcement of the successful initiation of the study and implantation for the total knee arthroplasty (TKA) on the very first patients with the new polymer, PEEK-OPTIMA™ femoral knee component. This component offers surgeons and patients a femoral component that has the ability to correct component to bone material mismatch.

In May 2022, DuPont announced the launch of a new spun yarn collection in collaboration with JP Modatex India, blending natural fibers with DuPont Sorona staple fibers. The collection combines linen and partially plant-based Sorona fibers to create spun yarns suitable for various applications, such as dresses, shirting, pants and skirts, denim, and jackets.

Types Covered
• Metallic Biomaterials
• Polymeric Biomaterials
• Ceramics
• Natural Biomaterials

Applications Covered
• Cardiovascular
• Orthopaedic
• Ophthalmology
• Dental
• Plastic Surgery
• Wound Healing
• Tissue Engineering
• Neurological/Central Nervous System Applications
• Other Applications

Regions Covered
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements